Advertiser Disclosure. Hims is an online telehealth platform for men that provides care for mental health, sexual health, hair loss, skincare and more. Outside of offering telehealth appointments ...

Hims & Hers is a fantastic value despite its high 'on-the-surface' P/E ratio and valuation metrics. The company's subscription-based model in healthcare, targeting chronic conditions, ensures ...

Telehealth company Hims & Hers Health (HIMS 3.09%) has been great for investors this year by almost any standard; share prices have nearly doubled from a year ago. Yet shareholders aren't feeling ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this ...

However, an industrywide shortage for the drugs opened the door for companies like Hims & Hers Health (NYSE: HIMS) to compete by offering lower-priced compounded versions mixed up by their teams.

Check out this chart that pits XYON vs other popular brands like Happy Head, Hims, Keeps, and Roman. $99/month ($297 quarterly) $50/month ($150 quarterly) ($270 bi-annually) ...

Hims & Hers Health (NYSE: HIMS) stock has been on a bit of a rollercoaster ride this year. The stock is down about 35% from the highs it hit earlier this year, but is it still up over 85% year to ...